Dilated cardiomyopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18-75, any gender; 2.Diagnosed with dilated cardiomyopathy; 3.Subjects or their legal guardians are fully informed of the nature and risks of the study, participate voluntarily, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Serious uncontrolled infection at enrolment ('uncontrolled' is defined as signs and symptoms of infection that persist without improvement despite antimicrobial or other treatment); 2.Uncontrolled active bleeding at enrollment; 3.Pregnancy or breastfeeding; 4.Combination of serious diseases affecting survival, such as tumors, with a life expectancy of less than one year; 5.Previous heart transplant or implantation of a cardiac assist device; 6.Patients with poor compliance who are unable to complete the full course of the study; 7.Other conditions (e.g., overstimulation, sensitivity, cognitive impairment, mental illness, or substance abuse/addiction) that, in the judgment of the investigator, may increase the risk to the subject or interfere with the clinical study and judgment of the results.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| All-cause death, heart transplant, heart failure rehospitalization, or sudden death; | — |
Primary
| Measure | Time frame |
|---|---|
| Composite Endpoint of All-Cause Death, Heart Transplantation, and Rehospitalization for Heart Failure; | — |
Countries
China
Contacts
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology